<p>Guiying Nie of Prince Henry's Institute of Medical Research in Australia will test whether a peptide inhibitor that has been shown to inhibit protein processing critical to HIV transmission can also be used to prevent embryo implantation in the uterus. If successful, the peptide could be used as a non-hormonal contraceptive delivered as a vaginal application, which also protects against HIV.</p>


Guiying Nie of Prince Henry's Institute of Medical Research in Australia will test whether a peptide inhibitor that has been shown to inhibit protein processing critical to HIV transmission can also be used to prevent embryo implantation in the uterus. If successful, the peptide could be used as a non-hormonal contraceptive delivered as a vaginal application, which also protects against HIV.